RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kabirullah Lutfy to Receptors, Opioid

This is a "connection" page, showing publications Kabirullah Lutfy has written about Receptors, Opioid.
Connection Strength

4.646
  1. Lutfy K, Hamid A, Zaveri NT. Small molecule NOP agonists reverse locomotor sensitization induced by cocaine in male C57BL/6 mice. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Apr 20; 131:110941.
    View in: PubMed
    Score: 0.923
  2. Zaveri NT, Marquez PV, Meyer ME, Polgar WE, Hamid A, Lutfy K. A Novel and Selective Nociceptin Receptor (NOP) Agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) Decreases Acquisition of Ethanol-Induced Conditioned Place Preference in Mice. Alcohol Clin Exp Res. 2018 Feb; 42(2):461-471.
    View in: PubMed
    Score: 0.610
  3. Lutfy K, Zaveri NT. The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction. Prog Mol Biol Transl Sci. 2016; 137:149-81.
    View in: PubMed
    Score: 0.528
  4. Marquez P, Hamid A, Lutfy K. The role of NOP receptors in psychomotor stimulation and locomotor sensitization induced by cocaine and amphetamine in mice. Eur J Pharmacol. 2013 May 05; 707(1-3):41-5.
    View in: PubMed
    Score: 0.436
  5. Marquez P, Borse J, Nguyen AT, Hamid A, Lutfy K. The role of the opioid receptor-like (ORL1) receptor in motor stimulatory and rewarding actions of buprenorphine and morphine. Neuroscience. 2008 Aug 26; 155(3):597-602.
    View in: PubMed
    Score: 0.314
  6. Marquez P, Nguyen AT, Hamid A, Lutfy K. The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine. Neuropharmacology. 2008 Mar; 54(3):564-8.
    View in: PubMed
    Score: 0.301
  7. Narayanan S, Lam H, Carroll FI, Lutfy K. Orphanin FQ/nociceptin suppresses motor activity through an action along the mesoaccumbens axis in rats. J Psychiatry Neurosci. 2004 Mar; 29(2):116-23.
    View in: PubMed
    Score: 0.233
  8. Lutfy K, Eitan S, Bryant CD, Yang YC, Saliminejad N, Walwyn W, Kieffer BL, Takeshima H, Carroll FI, Maidment NT, Evans CJ. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. J Neurosci. 2003 Nov 12; 23(32):10331-7.
    View in: PubMed
    Score: 0.228
  9. Lutfy K, Sharza SA, Maidment NT. Tolerance develops to the inhibitory effect of orphanin FQ on morphine-induced antinociception in the rat. Neuroreport. 1999 Jan 18; 10(1):103-6.
    View in: PubMed
    Score: 0.163
  10. Meyer LC, Paisley CE, Mohamed E, Bigbee JW, Kordula T, Richard H, Lutfy K, Sato-Bigbee C. Novel role of the nociceptin system as a regulator of glutamate transporter expression in developing astrocytes. Glia. 2017 12; 65(12):2003-2023.
    View in: PubMed
    Score: 0.149
  11. Lutfy K, Sadowski B, Kwon IS, Weber E. Morphine analgesia and tolerance in mice selectively bred for divergent swim stress-induced analgesia. Eur J Pharmacol. 1994 Nov 24; 265(3):171-4.
    View in: PubMed
    Score: 0.123
  12. Lutfy K, Yoburn BC. The role of opioid receptor density in morphine tolerance. J Pharmacol Exp Ther. 1991 Feb; 256(2):575-80.
    View in: PubMed
    Score: 0.094
  13. Yoburn BC, Sierra V, Lutfy K. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation. Brain Res. 1990 Oct 08; 529(1-2):143-8.
    View in: PubMed
    Score: 0.092
  14. Farhang B, Pietruszewski L, Lutfy K, Wagner EJ. The role of the NOP receptor in regulating food intake, meal pattern, and the excitability of proopiomelanocortin neurons. Neuropharmacology. 2010 Sep; 59(3):190-200.
    View in: PubMed
    Score: 0.090
  15. Yoburn BC, Sierra V, Lutfy K. Chronic opioid antagonist treatment: assessment of receptor upregulation. Eur J Pharmacol. 1989 Nov 07; 170(3):193-200.
    View in: PubMed
    Score: 0.086
  16. Lutfy K, Khaliq I, Carroll FI, Maidment NT. Orphanin FQ/nociceptin blocks cocaine-induced behavioral sensitization in rats. Psychopharmacology (Berl). 2002 Nov; 164(2):168-76.
    View in: PubMed
    Score: 0.052
  17. Narayanan S, Lutfy K, Maidment N. Sensitization to cocaine after a single intra-cerebral injection of orphanin FQ/nociceptin. Behav Brain Res. 2002 Apr 01; 131(1-2):97-103.
    View in: PubMed
    Score: 0.051
  18. Taylor AM, Roberts KW, Pradhan AA, Akbari HA, Walwyn W, Lutfy K, Carroll FI, Cahill CM, Evans CJ. Anti-nociception mediated by a ? opioid receptor agonist is blocked by a d receptor agonist. Br J Pharmacol. 2015 Jan; 172(2):691-703.
    View in: PubMed
    Score: 0.030
  19. Candido J, Lutfy K, Billings B, Sierra V, Duttaroy A, Inturrisi CE, Yoburn BC. Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation. Pharmacol Biochem Behav. 1992 Aug; 42(4):685-92.
    View in: PubMed
    Score: 0.026
  20. Sierra V, Duttaroy A, Lutfy K, Candido J, Billings B, Zito SW, Yoburn BC. Potentiation of opioid analgesia by cocaine: the role of spinal and supraspinal receptors. Life Sci. 1992; 50(8):591-7.
    View in: PubMed
    Score: 0.025
  21. Chang SC, Lutfy K, Sierra V, Yoburn BC. Dissociation of opioid receptor upregulation and functional supersensitivity. Pharmacol Biochem Behav. 1991 Apr; 38(4):853-9.
    View in: PubMed
    Score: 0.024
  22. Yoburn BC, Lutfy K, Candido J. Species differences in mu- and delta-opioid receptors. Eur J Pharmacol. 1991 Jan 25; 193(1):105-8.
    View in: PubMed
    Score: 0.023
  23. Yoburn BC, Lutfy K, Azimuddin S, Sierra V. Differentiation of spinal and supraspinal opioid receptors by morphine tolerance. Life Sci. 1990; 46(5):343-50.
    View in: PubMed
    Score: 0.022
  24. Yoburn BC, Paul D, Azimuddin S, Lutfy K, Sierra V. Chronic opioid antagonist treatment increases mu and delta receptor mediated spinal opioid analgesia. Brain Res. 1989 Apr 17; 485(1):176-8.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support